Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus

Detalhes bibliográficos
Autor(a) principal: Vicenzi, Camila
Data de Publicação: 2019
Outros Autores: Moehlecke, Milene
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/82726
Resumo: Background: Evidence in the literature indicates that patients with type 2 diabetes  (T2D) have a very low level of adherence to pharmacological treatment and that despite several interventions to improve it, a number of obstacles to optimal care limit the extent to which such goals can be achieved.Aims: To assess the sociodemographic profile of patients with T2D, describing prevalence of adherence to drug treatment among them. Additionally, this study attempts to identify the main reasons for nonadherence.Methods: This cross-sectional study evaluated patients with T2D for at least 6 months who are regularly followed at an endocrinology outpatient clinic or who have been admitted to a university hospital. Adherence was assessed by a modified Morisky-Green test and the Batalla test.Results: Ninety-six patients were included, mostly women (59%), white (76%), and with mean age of 52 ± 12 years. Only 49% of patients adhered to drug treatment according to the Batalla test, while 24% were classified as high adherence, 41% as moderate adherence and 34% as low adherence to drug treatment according to the modified Morisky-Green test. Considering glycated hemoglobin levels as a reference method, only 37% of patients were within the currently recommended values, with higher adherence among women compared to men (44% vs. 23%, P = 0.044).Conclusion: The prevalence of adherence among patients with T2D was very low. Older age, insulin therapy and male sex were more strongly associated with worse adherence. The main barrier limiting treatment adherence was lack of motivation, especially due to difficulties in adopting a healthy and balanced diet.Keywords: Type 2 diabetes; adherence; chronic disease
id UFRGS-20_0fe5acc708325fea68ad6b6cba41b7aa
oai_identifier_str oai:seer.ufrgs.br:article/82726
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitusType 2 diabetesadherencechronic diseaseBackground: Evidence in the literature indicates that patients with type 2 diabetes  (T2D) have a very low level of adherence to pharmacological treatment and that despite several interventions to improve it, a number of obstacles to optimal care limit the extent to which such goals can be achieved.Aims: To assess the sociodemographic profile of patients with T2D, describing prevalence of adherence to drug treatment among them. Additionally, this study attempts to identify the main reasons for nonadherence.Methods: This cross-sectional study evaluated patients with T2D for at least 6 months who are regularly followed at an endocrinology outpatient clinic or who have been admitted to a university hospital. Adherence was assessed by a modified Morisky-Green test and the Batalla test.Results: Ninety-six patients were included, mostly women (59%), white (76%), and with mean age of 52 ± 12 years. Only 49% of patients adhered to drug treatment according to the Batalla test, while 24% were classified as high adherence, 41% as moderate adherence and 34% as low adherence to drug treatment according to the modified Morisky-Green test. Considering glycated hemoglobin levels as a reference method, only 37% of patients were within the currently recommended values, with higher adherence among women compared to men (44% vs. 23%, P = 0.044).Conclusion: The prevalence of adherence among patients with T2D was very low. Older age, insulin therapy and male sex were more strongly associated with worse adherence. The main barrier limiting treatment adherence was lack of motivation, especially due to difficulties in adopting a healthy and balanced diet.Keywords: Type 2 diabetes; adherence; chronic diseaseHCPA/FAMED/UFRGS2019-02-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/82726Clinical & Biomedical Research; Vol. 38 No. 4 (2018): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 38 n. 4 (2018): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/82726/pdfCopyright (c) 2019 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessVicenzi, CamilaMoehlecke, Milene2024-01-19T14:22:37Zoai:seer.ufrgs.br:article/82726Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:22:37Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
title Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
spellingShingle Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
Vicenzi, Camila
Type 2 diabetes
adherence
chronic disease
title_short Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
title_full Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
title_fullStr Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
title_full_unstemmed Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
title_sort Prevalence of adherence to pharmacological treatment in patients with type 2 diabetes mellitus
author Vicenzi, Camila
author_facet Vicenzi, Camila
Moehlecke, Milene
author_role author
author2 Moehlecke, Milene
author2_role author
dc.contributor.author.fl_str_mv Vicenzi, Camila
Moehlecke, Milene
dc.subject.por.fl_str_mv Type 2 diabetes
adherence
chronic disease
topic Type 2 diabetes
adherence
chronic disease
description Background: Evidence in the literature indicates that patients with type 2 diabetes  (T2D) have a very low level of adherence to pharmacological treatment and that despite several interventions to improve it, a number of obstacles to optimal care limit the extent to which such goals can be achieved.Aims: To assess the sociodemographic profile of patients with T2D, describing prevalence of adherence to drug treatment among them. Additionally, this study attempts to identify the main reasons for nonadherence.Methods: This cross-sectional study evaluated patients with T2D for at least 6 months who are regularly followed at an endocrinology outpatient clinic or who have been admitted to a university hospital. Adherence was assessed by a modified Morisky-Green test and the Batalla test.Results: Ninety-six patients were included, mostly women (59%), white (76%), and with mean age of 52 ± 12 years. Only 49% of patients adhered to drug treatment according to the Batalla test, while 24% were classified as high adherence, 41% as moderate adherence and 34% as low adherence to drug treatment according to the modified Morisky-Green test. Considering glycated hemoglobin levels as a reference method, only 37% of patients were within the currently recommended values, with higher adherence among women compared to men (44% vs. 23%, P = 0.044).Conclusion: The prevalence of adherence among patients with T2D was very low. Older age, insulin therapy and male sex were more strongly associated with worse adherence. The main barrier limiting treatment adherence was lack of motivation, especially due to difficulties in adopting a healthy and balanced diet.Keywords: Type 2 diabetes; adherence; chronic disease
publishDate 2019
dc.date.none.fl_str_mv 2019-02-19
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/82726
url https://seer.ufrgs.br/index.php/hcpa/article/view/82726
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/82726/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 38 No. 4 (2018): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 38 n. 4 (2018): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767054626062336